Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Crescita Therapeutics Inc (CRRTF)

Crescita Therapeutics Inc (CRRTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CRRTF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3200 unch
on 04/02/24
0.3200 unch
on 04/02/24
N/A (-0.16%)
since 02/23/24
3-Month
0.3200 unch
on 04/02/24
0.3850 -16.88%
on 01/09/24
+0.0400 (+14.29%)
since 12/19/23
52-Week
0.2500 +28.00%
on 11/28/23
0.5500 -41.82%
on 07/13/23
-0.1900 (-37.25%)
since 03/07/23

Most Recent Stories

More News
Crescita Reports Q4 and Fiscal 2022 Results

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“ Crescita ” or the “ Company ”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial...

OTC.VN : 0.345 (-1.43%)
CTX.TO : 0.4200 (unch)
CRRTF : 0.3200 (-0.16%)
Crescita Reports Third Quarter 2022 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial...

OTC.VN : 0.345 (-1.43%)
CTX.TO : 0.4200 (unch)
CRRTF : 0.3200 (-0.16%)
Crescita Reports Second Quarter 2022 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial...

OTC.VN : 0.345 (-1.43%)
CTX.TO : 0.4200 (unch)
CRRTF : 0.3200 (-0.16%)
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results...

OTC.VN : 0.345 (-1.43%)
CTX.TO : 0.4200 (unch)
CRRTF : 0.3200 (-0.16%)
Crescita Reports First Quarter 2022 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial...

OTC.VN : 0.345 (-1.43%)
CTX.TO : 0.4200 (unch)
CRRTF : 0.3200 (-0.16%)
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”) today announced that its CEO, Serge Verreault, will be presenting at the 2022 Bloom Burton & Co. Healthcare Investor...

OTC.VN : 0.345 (-1.43%)
CTX.TO : 0.4200 (unch)
CRRTF : 0.3200 (-0.16%)
Crescita Reports Q4 and Fiscal 2021 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial...

OTC.VN : 0.345 (-1.43%)
CTX.TO : 0.4200 (unch)
CRRTF : 0.3200 (-0.16%)
Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“ Crescita ” or the “ Company ”) announced today that the Toronto Stock Exchange (the “ TSX ”) has approved the Company’s renewal of...

OTC.VN : 0.345 (-1.43%)
CTX.TO : 0.4200 (unch)
CRRTF : 0.3200 (-0.16%)
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita”), a growth-oriented, innovation-driven Canadian commercial dermatology company, is pleased to announce that it has signed an exclusive...

OTC.VN : 0.345 (-1.43%)
CTX.TO : 0.4200 (unch)
CRRTF : 0.3200 (-0.16%)
Crescita Reports Third Quarter 2021 Results and Appoints New Board Member

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial...

OTC.VN : 0.345 (-1.43%)
CTX.TO : 0.4200 (unch)
CRRTF : 0.3200 (-0.16%)

Key Turning Points

3rd Resistance Point 0.3200
2nd Resistance Point 0.3200
1st Resistance Point 0.3200
Last Price 0.3200
1st Support Level 0.3200
2nd Support Level 0.3200
3rd Support Level 0.3200

See More

52-Week High 0.5500
Fibonacci 61.8% 0.4354
Fibonacci 50% 0.4000
Fibonacci 38.2% 0.3646
Last Price 0.3200
52-Week Low 0.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar